Amplity Rebrands AI-Powered, HIPAA-Compliant Platform To Amplity AnswerY™

FOR IMMEDIATE RELEASE

Langhorne, PA | January 16, 2025

Transforming Doctor-Patient Conversations Into Actionable Insights For Biopharma Leaders

 Amplity, a full-service partner for outsourcing flexible medical and commercial services, medical communications, life sciences training, and tech-enabled intelligence, announced the rebranding of its proprietary, AI-powered, HIPAA-compliant platform from Amplity Insights™ to Amplity AnswerY™.

This change reflects Amplity’s bold commitment to providing actionable, context-rich intelligence that reveals the “why” behind healthcare provider (HCP) behavior, enabling biopharma leaders to make smarter, faster, and more impactful decisions.

Amplity AnswerY: A New Identity For A Proven HIPAA-Compliant Platform

The rebranding of AnswerY comes as part of Amplity’s broader company transformation, which included the launch of a new website and refreshed corporate brand earlier this year. With this new identity, the platform continues to deliver unparalleled, HIPAA-compliant insights derived from tens of millions of doctor-patient conversations since 2017.

“Amplity AnswerY represents a significant step forward in our mission to empower the biopharma industry with intel that moves beyond the ‘what’ to uncover the critical ‘why’ behind treatment decisions,” said Chris Baker, Amplity CEO. “AnswerY doubles down on our commitment to providing smarter strategies, sharper insights, and real ROI for our client partners. This rebrand is more than a name change—it’s a reflection of the impact our AI-driven, HIPAA-complaint platform delivers every day.”

Originally launched as RealHealthData in 2014, the platform was acquired by Amplity in 2020 and subsequently renamed Amplity Insights. In late 2024, Amplity consolidated its database (formerly known as Xplore) and analytics platform under a single, cohesive identity: Amplity AnswerY.

Unlocking The Power of Doctor-Patient Conversations

AnswerY leverages unstructured data from doctor-patient conversations to provide real-time, unbiased insights into prescriber and patient behavior—capabilities that traditional claims or EHR datasets simply cannot match.

How Amplity Drives Results Across The Biopharma Industry

• Marketing leaders can take primary market research to new levels—at a fraction of the time and cost—enabling precise segmentation and messaging using real-time behavioral information.
• Sales teams can identify hard to reach populations (like patients with rare diseases), target the right HCPs, and customize their pre-call planning and follow-up activities to drive more scripts.
• Medical teams can identify patients to advance clinical trial enrollment and tailor their KOL engagements to achieve desired educational goals.
• Real-world data leaders can create more robust and less costly P4 and health economics outcomes studies using HIPAA-compliant prescriber sentiment.

The Platform For Smarter Biopharma Strategies

With over 250 million lab test mentions, 55 million treatment patterns, and coverage across every therapeutic area and care setting, AnswerY delivers the most comprehensive and up-to-date qualitative intelligence available to biopharma companies.

The platform processes over 1 million new records monthly, ensuring data is refreshed every 30 days to maintain relevance and accuracy. By transforming doctor-patient conversations into actionable insights, AnswerY empowers biopharma organizations to improve product sales, cut costs, drive growth, save time, and make more informed decisions.

About Amplity

Pharma At Its Best: Quicker. Better. Nicer

We are your full-service go-to partners delivering both flexible and specialized medical and commercial services. No matter where you are in the lifecycle of your drug, we scale with ease to maximize resources and improve impact. Our people-driven, tech-enabled DNA fuels everything we do.

To contact Amplity’s Marketing and PR team, please email [email protected]